Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Biogen Inc.

Market Cap 29.02B 25.3B 23.44B 21.94B 41.15B 2,738B 41.39B 278B 108B 1,348B 109B 107B 4,680B P/E 2026 *
31.7x
P/E 2027 * 16.5x
Enterprise Value 34.39B 29.99B 27.77B 26B 48.76B 3,245B 49.06B 329B 128B 1,597B 129B 126B 5,547B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.12x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+2.56%
1 week+2.56%
Current month+5.61%
1 month+5.56%
3 months+2.24%
6 months+5.53%
Current year+10.49%
1 month 158.96
Extreme 158.96
192
Current year 134.7
Extreme 134.7
192
1 year 103.75
Extreme 103.75
192
3 years 99
Extreme 99
309.8
5 years 99
Extreme 99
351.7
10 years 99
Extreme 99
351.7
Manager TitleAgeSince
Chief Executive Officer 66 13/11/2022
Director of Finance/CFO 60 28/02/2025
Chief Tech/Sci/R&D Officer - 31/12/2020
Director TitleAgeSince
Director/Board Member 69 22/03/2010
Director/Board Member 77 31/12/2009
Director/Board Member 72 18/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.56%+2.56% - - 29.02B
+0.33%-0.36%+18.76%-22.11% 62.05B
+0.20%-9.17%+58.39%+196.56% 54.52B
-3.92%+37.40%+37.40%+37.40% 41.55B
+7.62%+8.19%-51.27%-59.11% 39.06B
+3.50%+28.15%+151.81%-50.31% 25.38B
-0.78%-9.50%+43.87%+55.34% 19.62B
+1.74%-0.39%-2.93%+113.90% 16.89B
-0.05%+0.23%+61.48%+101.93% 15.89B
-1.66%-0.79%+65.68%+341.51% 12.98B
Average +0.95%+2.75%+42.58%+79.46% 31.99B
Weighted average by Cap. +1.01%+1.91%+36.09%+56.87%

Financials

2026 *2027 *
Net sales 10.05B 8.76B 8.12B 7.6B 14.25B 949B 14.34B 96.3B 37.32B 467B 37.73B 36.92B 1,621B 10.38B 9.05B 8.38B 7.85B 14.72B 980B 14.81B 99.45B 38.54B 482B 38.97B 38.13B 1,674B
Net income 1.18B 1.03B 951M 890M 1.67B 111B 1.68B 11.28B 4.37B 54.67B 4.42B 4.32B 190B 1.97B 1.72B 1.59B 1.49B 2.79B 186B 2.81B 18.86B 7.31B 91.43B 7.39B 7.23B 317B
Net Debt 5.37B 4.68B 4.34B 4.06B 7.62B 507B 7.66B 51.46B 19.94B 250B 20.17B 19.73B 866B 3.35B 2.92B 2.71B 2.53B 4.75B 316B 4.78B 32.09B 12.44B 156B 12.57B 12.3B 540B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Trader
Investor
Global
Quality
ESG MSCI
AA
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!